Stalevo 150 mg/37.5 mg/200 mg film-coated tablets

Company
Orion Pharma (Ireland) Ltd
Active Ingredient
Dosage Form
Infus/Pdr/Oral Soln
Legal Category
B - prescription, may be renewed
Date of revision
01/2022

*further information is available on request to the holder of the authorisation or in the SPC

Licence number Strength ATC Code Dosage Form
EU/1/03/260/009 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/010 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/011 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/012 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/15 N04BA, N04BA03 Infus/Pdr/Oral Soln
EU/1/03/260/18 N04BA, N04BA03 Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/009
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/010
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/011
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/012
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/15
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln
Licence number
EU/1/03/260/18
Strength
–
ATC Code
N04BA, N04BA03
Dosage Form
Infus/Pdr/Oral Soln

Orion Pharma (Ireland) Ltd

c/o Allphar Services Ltd, 4045 Kingswood Road, Citywest Business Park, Co Dublin D24V06K

Website
https://www.orionpharma.ie
Telephone
+35314688482
Email
ie.medicalinformation@orionpharma.com